Progressive neuroanatomical changes caused by Grin1 loss-of-function mutation

[1]  H. Goodkin,et al.  Pathophysiology of convulsive status epilepticus , 2019, Seizure.

[2]  Consequences of NMDA receptor deficiency can be rescued in the adult brain , 2017 .

[3]  D. Menon,et al.  Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: A systematic review , 2018, Journal of Clinical Neuroscience.

[4]  H. Mefford,et al.  De novo mutations in GRIN1 cause extensive bilateral polymicrogyria , 2018, Brain : a journal of neurology.

[5]  K. Ohno,et al.  Rare loss of function mutations in N-methyl-d-aspartate glutamate receptors and their contributions to schizophrenia susceptibility , 2018, Translational Psychiatry.

[6]  Shantanu H. Joshi,et al.  Superficial white matter damage in anti-NMDA receptor encephalitis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[7]  C. Hedin-Pereira,et al.  The fine tuning of retinocollicular topography depends on reelin signaling during early postnatal development of the rat visual system , 2017, Neuroscience.

[8]  R. Rodriguiz,et al.  5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice , 2017, Neuropsychopharmacology.

[9]  A. Salahpour,et al.  Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction , 2017, npj Schizophrenia.

[10]  J. Graham,et al.  GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function , 2017, Journal of Human Genetics.

[11]  D. Ville,et al.  Novel homozygous missense variant of GRIN1 in two sibs with intellectual disability and autistic features without epilepsy , 2017, European Journal of Human Genetics.

[12]  S. P. Moran,et al.  Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256. , 2016, ACS chemical neuroscience.

[13]  J. Dalmau,et al.  Anti-NMDA receptor encephalitis, autoimmunity, and psychosis , 2016, Schizophrenia Research.

[14]  D. Misceo,et al.  Delineating the GRIN1 phenotypic spectrum , 2016, Neurology.

[15]  A. Jenkins,et al.  Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases , 2015, Molecular Pharmacology.

[16]  D. Lev,et al.  GRIN1 mutations cause encephalopathy with infantile‐onset epilepsy, and hyperkinetic and stereotyped movement disorders , 2015, Epilepsia.

[17]  C. Mielnik,et al.  NMDA receptor‐deficient mice display sexual dimorphism in the onset and severity of behavioural abnormalities , 2014, Genes, brain, and behavior.

[18]  M. Mallar Chakravarty,et al.  Pydpiper: a flexible toolkit for constructing novel registration pipelines , 2014, Front. Neuroinform..

[19]  T. Sotnikova,et al.  Sustained N‐methyl‐d‐aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling , 2014, The European journal of neuroscience.

[20]  A. Wheeler,et al.  A review of structural neuroimaging in schizophrenia: from connectivity to connectomics , 2014, Front. Hum. Neurosci..

[21]  Qiang Zhou,et al.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease , 2013, Nature Reviews Neuroscience.

[22]  J. Buizer-Voskamp,et al.  Genetic Schizophrenia Risk Variants Jointly Modulate Total Brain and White Matter Volume , 2013, Biological Psychiatry.

[23]  S. Siegel,et al.  Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? , 2012, Genes, brain, and behavior.

[24]  C. Harley,et al.  Olfactory Bulb Glomerular NMDA Receptors Mediate Olfactory Nerve Potentiation and Odor Preference Learning in the Neonate Rat , 2012, PloS one.

[25]  Lindsay S. Cahill,et al.  Preparation of fixed mouse brains for MRI , 2012, NeuroImage.

[26]  B. Koller,et al.  Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function , 2012, Brain Research.

[27]  R. McCarley,et al.  Olfactory sulcal depth and olfactory bulb volume in patients with schizophrenia: an MRI study , 2011, Brain Imaging and Behavior.

[28]  G. Ming,et al.  Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions , 2011, Neuron.

[29]  Leming Shi,et al.  Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia , 2011, International Journal of Developmental Neuroscience.

[30]  M. Caron,et al.  Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner , 2011, Proceedings of the National Academy of Sciences.

[31]  R. Huganir,et al.  Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. , 2011, American journal of human genetics.

[32]  Brian B. Avants,et al.  The optimal template effect in hippocampus studies of diseased populations , 2010, NeuroImage.

[33]  B. Peterson,et al.  Normal Development of Brain Circuits , 2010, Neuropsychopharmacology.

[34]  R. Gur,et al.  Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia , 2009, Genes, brain, and behavior.

[35]  M. Nicolelis,et al.  Hyperdopaminergia and NMDA Receptor Hypofunction Disrupt Neural Phase Signaling , 2009, The Journal of Neuroscience.

[36]  R. Mark Henkelman,et al.  High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl/6J mice , 2008, NeuroImage.

[37]  Michael R. Hayden,et al.  Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease , 2008, Neurobiology of Disease.

[38]  Hilleke E. Hulshoff Pol,et al.  Progressive Brain Volume Loss in Schizophrenia Over the Course of the Illness: Evidence of Maturational Abnormalities in Early Adulthood , 2008, Biological Psychiatry.

[39]  H. Galehdari.  Association Between the G1001C Polymorphism in the GRIN1 Gene Promoter and Schizophrenia in the Iranian Population , 2008, Journal of Molecular Neuroscience.

[40]  D. Purpura,et al.  NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders , 2007, Nature Reviews Neuroscience.

[41]  Jun Dazai,et al.  MR technology for biological studies in mice , 2007, NMR in biomedicine.

[42]  R. Kikinis,et al.  A review of diffusion tensor imaging studies in schizophrenia. , 2007, Journal of psychiatric research.

[43]  J. Lieberman,et al.  Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction , 2006, Pharmacology Biochemistry and Behavior.

[44]  S. Takikita,et al.  Experimental cortical dysplasia following ibotenate administration in hamsters: Pathogenesis of microgyria and associated gray matter heterotopia , 2005, Congenital anomalies.

[45]  L. Schmued,et al.  Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons , 2005, Brain Research.

[46]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[47]  F. Fumagalli,et al.  Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia , 2003, Biological Psychiatry.

[48]  G. Laviola,et al.  Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents , 2003, Neuroscience & Biobehavioral Reviews.

[49]  R. Kahn,et al.  Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. , 2002, Archives of general psychiatry.

[50]  R. Conley,et al.  Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. , 2000, The American journal of psychiatry.

[51]  F. Sharp,et al.  Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK‐801) injures pyramidal neurons in rat retrosplenial cortex , 2000, The European journal of neuroscience.

[52]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[53]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[54]  Hee-Sup Shin,et al.  Mutant Mice and Neuroscience: Recommendations Concerning Genetic Background , 1997, Neuron.

[55]  E. Gould,et al.  Neurogenesis in the Dentate Gyrus of the Adult Tree Shrew Is Regulated by Psychosocial Stress and NMDA Receptor Activation , 1997, The Journal of Neuroscience.

[56]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[57]  J. Connor,et al.  Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death , 1994, Neuron.

[58]  D. Collins,et al.  Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.

[59]  Susumu Tonegawa,et al.  Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice , 1994, Cell.

[60]  S. Nakanishi,et al.  Molecular cloning and characterization of the rat NMDA receptor , 1991, Nature.

[61]  B. Pakkenberg,et al.  Post-mortem Study of Chronic Schizophrenic Brains , 1987, British Journal of Psychiatry.

[62]  R Jagoe,et al.  Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. , 1986, Archives of general psychiatry.

[63]  T. Tapper.  Drug abuse in adolescence. , 1969, Pediatrics.